Nancy Yacovzada

predicTTE: An accessible and optimal tool for time-to-event prediction in neurological diseases

E. Elhaik, E. Hornstein, K. Kenna, 2024, bioRxiv.

Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk gene.

D. Lancet, M. Snyder, A. Al-Chalabi, 2021, Cell reports.

Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk Gene

D. Lancet, M. Snyder, J. Landers, 2020, Cell reports.